Number of Shares
3.24 Mil
Current Holdings Value*
$14.33 Mil
% of Portfolio
9.56%
Total Estimate Gain
$-23.03 Mil
% of Total Estimate Gain
-62.28%

ACORN CAPITAL ADVISORS, LLC's Y-mAbs Therapeutics Inc Holding Summary

As of 2025-03-31, ACORN CAPITAL ADVISORS, LLC held 3.24 Mil shares of Y-mAbs Therapeutics Inc(YMAB), totaling $14.33 Mil. This investment constitutes 9.56% of their stock portfolio, and ACORN CAPITAL ADVISORS, LLC now holds 7.15% of the outstanding Y-mAbs Therapeutics Inc(YMAB) stock.

The initial trade took place in 2024Q4. And since then ACORN CAPITAL ADVISORS, LLC has made 1 purchases of YMAB, at an average price of $11.43, for a total of 3.24 Mil shares. Based on historical transaction data and YMAB's current price of $4.31, ACORN CAPITAL ADVISORS, LLC's estimated gain on his YMAB holdings is $-23.03 Mil, reflecting a -62.28% gain to date.

ACORN CAPITAL ADVISORS, LLC YMAB ($4.31) Holding Chart

ACORN CAPITAL ADVISORS, LLC YMAB ($4.31) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1